Address: C-37-3, Block C, Jaya One, 72A, Jalan Universiti 46200 Petaling Jaya,Malaysia
Tel: 03-7960 8322/23
The Pharmaceutical Association of Malaysia (PhAMA) was registered in 1972. Today, the Association represents the interests of 46 member companies and 3 associate members. Members of the Association consist of importers, distributors and manufacturers of medicines and covers both local concerns and multinational corporations. The Board of directors consists of thirteen members, namely the President, 2 Vice Presidents, an Immediate Past-President and 9 Board Directors.
The Association is affiliated to the International Federation of Pharmaceutical Manufacturers & Association (IFPMA) and also World Self-Medication Industry (WSMI). IFPMA members are companies manufacturing and marketing ethical products while members of the WSMI are those manufacturing and marketing Over-The-Counter (OTC) pharmaceuticals products. Both bodies are non-governmental organisations (NGOs) and are affiliated to the World Health Organisation (WHO).
Obectives:
Promoting timely access to quality and innovative medicines
Encouraging research and development of pharmaceutical products in Malaysia
Forming strategic health partnership with key stakeholders for the advancement of public health
Empowering consumers for safe and responsible self-medication
Promoting industries values and contribution to the nation
Upgrading the skills and knowledge of industry’s human resource
Ensuring the ethical promotion of medicines in compliance with local laws and a set of marketing practices
Representations at various level of Government meetings and as the mouthpiece for the pharmaceutical industry
Dissemination channel for various Government policies and circulars
Monthly Telefax Turnover Survey
Yearly Remuneration Survey
Bi-yearly Distance Learning Programme
MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the importance of leveraging learnings from the past year to create a more…
PhAMA was started in 1972 and now has most of the MNC players among its members which include 43 companies. How has the association evolved since its origin and what…
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Dr Hyzan Mohd Yusof, CEO at OSA Technology, tells the story of how he founded the company to address Malaysia’s unmet needs in medical devices as well as his vision…
How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia. Inno Bio Ventures, a Malaysian state-owned company originally set up to create…
Dr Ramli Zainal, the director at National Pharmaceutical Regulatory Agency (NPRA), expresses the continuous work of NPRA to build a strong regulatory ecosystem in Malaysia and the important role that…
Tan Sri Rahman Mamat, chairman of Inno Bio Ventures, provides his vision for biosimilars’ potential in Malaysia, and the progress the company has made in laying the foundations to make…
George Kazzi, general manager of Baxter Malaysia, highlights the main areas of development for his affiliate, including the introduction of more renal dialysis innovation as well as increasing awareness and…
Dr Dhesi Baha Raja, consultant in digital technologies at the Malaysian Ministry of Health, introduces the government’s plan to enter digital health through electronic medical records (EMR) and shares his…
Kshitij Panse, director of Servier Malaysia discusses the company’s planned move into oncology, as well as their strategies to provide an all-round improved patient experience, through education, screening, and e-health.…
Datuk Dr Noor Hisham Abdullah, director general of health at the Ministry of Health of Malaysia unveils the government’s plan to bring healthcare back to the community, and create a…
Dr. Azrul Mohd Khalib, chief executive at the Galen Centre for Health and Social Policy, gives an insight on the current important issues the Malaysian healthcare ecosystem is facing and…
Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination. …
Shahnas Oli Mohamed, the managing director of Natural Wellness Holdings Sdn Bhd, expresses the important work that Natural Wellness has done to provide natural healthcare products to Malaysian patients, including…
See our Cookie Privacy Policy Here
